Orion Therapeutics
KNOXVILLE, TN · Biotechnology · 9 employees
Orion Therapeutics Inc. is engaged in helping our clients discover and develop early-stage DNA/RNA therapeutics and vaccines by providing targeted, non-viral delivery systems that are safe and effective. The primary barrier to success of RNA and DNA clinical trials is the lack of an adequate delivery system. Our patented lipid nanoparticles are comprised of 100% natural components and incorporate
Funding history
- Series pre-seed — $85K — Sep 2024
- Series pre-seed — $60K — Dec 2022
Recent signals
- Sep 25, 2024: Raised $85K in Series pre-seed
- Dec 14, 2022: Raised $60K in Series pre-seed
See plans & pricing → Track Orion Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.